James J. Ferguson
2022
In 2022, James J. Ferguson earned a total compensation of $869.1K as Chief Medical Officer at Matinas BioPharma Holdings, a 46% decrease compared to previous year.
Compensation breakdown
| Bonus | $169,920 |
|---|---|
| Option Awards | $249,179 |
| Salary | $450,000 |
| Total | $869,099 |
Ferguson received $450K in salary, accounting for 52% of the total pay in 2022.
Ferguson also received $169.9K in bonus and $249.2K in option awards.
Rankings
In 2022, James J. Ferguson's compensation ranked 3,274th out of 5,534 executives tracked by ExecPay. In other words, Ferguson earned more than 40.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,274 out of 5,534 | 41st |
Division Manufacturing | 1,839 out of 3,000 | 39th |
Major group Chemicals And Allied Products | 870 out of 1,350 | 36th |
Industry group Drugs | 813 out of 1,253 | 35th |
Industry Pharmaceutical Preparations | 591 out of 907 | 35th |
Source: SEC filing on September 19, 2023.
Ferguson's colleagues
We found two more compensation records of executives who worked with James J. Ferguson at Matinas BioPharma Holdings in 2022.